|
POLR2I expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62714286489063E-12 |
| Normal-vs-Stage2 |
2.563800E-04 |
| Normal-vs-Stage3 |
3.94809740456026E-11 |
| Normal-vs-Stage4 |
1.14270000128869E-08 |
| Stage1-vs-Stage2 |
7.212400E-01 |
| Stage1-vs-Stage3 |
7.538600E-01 |
| Stage1-vs-Stage4 |
3.165200E-01 |
| Stage2-vs-Stage3 |
5.807200E-01 |
| Stage2-vs-Stage4 |
3.192800E-01 |
| Stage3-vs-Stage4 |
4.727000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.16480000037045E-07 |
| Normal-vs-Asian |
3.139600E-01 |
| Caucasian-vs-AfricanAmerican |
5.577700E-02 |
| Caucasian-vs-Asian |
7.373400E-01 |
| AfricanAmerican-vs-Asian |
3.542600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.10322861957002E-12 |
| Male-vs-Female |
4.230400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.217000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.40443212615082E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(81-100Yrs) |
3.436200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.439600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.498600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.682400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.510800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.278600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.54469999999307E-05 |
| Normal-vs-Grade 2 |
2.34146035893446E-13 |
| Normal-vs-Grade 3 |
1.11022302462516E-16 |
| Normal-vs-Grade 4 |
8.5263000004776E-07 |
| Grade 1-vs-Grade 2 |
9.152400E-01 |
| Grade 1-vs-Grade 3 |
6.511000E-01 |
| Grade 1-vs-Grade 4 |
9.369400E-01 |
| Grade 2-vs-Grade 3 |
3.558200E-01 |
| Grade 2-vs-Grade 4 |
9.610800E-01 |
| Grade 3-vs-Grade 4 |
4.712000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
3.80939999999885E-05 |
| ccA subtype-vs-ccB subtype |
4.00529999999844E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41309227944475E-12 |
| Normal-vs-N1 |
3.765500E-02 |
| N0-vs-N1 |
5.111600E-01 |
|
|
